Skip to content
MedsAcross

Brand family

Releuko

Filgrastim · Amneal Pharmaceuticals
United States
Presentations
4
Markets
1

Releuko is a brand of Filgrastim marketed by Amneal Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Filgrastim
Brand owner
Amneal Pharmaceuticals
Registered in
United States
Strengths and forms
300 mcg/0.5 mL injection, 300 mcg/1 mL injection, 480 mcg/0.8 mL injection, 480 mcg/1.6 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Releuko 300 mcg/0.5 mL injectionIntravenous, subcutaneous Cold chainAmneal PharmaceuticalsUS FDAAvailable on request
Releuko 300 mcg/1 mL injectionIntravenous, subcutaneous Cold chainAmneal PharmaceuticalsUS FDAAvailable on request
Releuko 480 mcg/0.8 mL injectionIntravenous, subcutaneous Cold chainAmneal PharmaceuticalsUS FDAAvailable on request
Releuko 480 mcg/1.6 mL injectionIntravenous, subcutaneous Cold chainAmneal PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Filgrastim.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Releuko

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.